Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

FORGOTTEN HISTORY: Cidara therapeutics s return on capital employed insights - Caught on Camera

According to Benzinga Pro data, during Q4, Cidara Therapeutics (NASDAQ:CDTX) posted sales of $7.22 million. Earnings were up 7.08%, but Cidara Therapeutics still reported an overall loss of $16.80 million. Cidara Therapeutics collected $7.08 million in revenue during Q3, but reported earnings showed a $18.08 million loss.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.